证券日报网讯万孚生物（300482）8月28日在互动平台回答投资者提问时表示，公司深耕体外诊断领域 30年，万孚生物持续响应社会对肝炎防治的健康需求，联动胶体金、免疫荧光、化学发光等平台上市了 超10款肝病检测产品，覆盖甲肝、乙肝、丙肝、戊肝及肝癌等，可为肝炎防治提供全面检测方案。随 着"星火计划"在广东及全国推进，相关创新成果将在更大范围内发挥作用，为更多地区肝炎筛查和防治 提供有力支持。 ...

Core Viewpoint - The World Health Organization (WHO) emphasizes the importance of combating hepatitis with available vaccines and effective treatments, aiming for the public health elimination of hepatitis threats by 2030 [1][2] Group 1: Hepatitis Overview - Viral hepatitis is an inflammation of the liver, categorized into five types: A, B, C, D, and E, which can lead to severe liver diseases and even liver cancer [1] - In 2022, there were 304 million people globally suffering from chronic hepatitis B and C, resulting in 1.3 million deaths, primarily due to liver cancer and cirrhosis [1] - Daily, there are approximately 6,000 new infections of hepatitis B and C worldwide [1] Group 2: Prevention and Treatment Recommendations - WHO recommends public screening for hepatitis B and C, vaccination of newborns within 24 hours of birth, and education on hepatitis knowledge to encourage early detection and treatment [1][2] - The World Hepatitis Alliance suggests providing safe drinking water, proper sewage management, and promoting hygiene practices to prevent hepatitis A and E [2] - WHO advises integrating hepatitis care with liver cancer prevention efforts and expanding affordable testing and treatment services [2]

Core Insights - Hepatitis is a significant public health issue affecting human health, with various types including viral hepatitis, alcoholic liver disease, and metabolic liver diseases [1][2] Group 1: Types of Hepatitis - Viral hepatitis primarily refers to hepatitis A, B, and C, but other factors such as alcohol, metabolism, immunity, drugs, chemicals, and parasites can also cause liver inflammation [1] - Hepatitis A and E are generally self-limiting and do not progress to chronic conditions, while certain populations like pregnant women and chronic liver disease patients may experience severe outcomes [1] - Hepatitis C can be effectively cured with direct-acting antiviral (DAA) treatments, achieving a cure rate for nearly all patients within 8-12 weeks, even in advanced stages [1] Group 2: Treatment and Management - Hepatitis B currently cannot be completely cured, and most patients require long-term antiviral therapy to control viral replication [2] - Some patients with hepatitis B may achieve functional cure with long-acting interferon, but those with decompensated cirrhosis cannot use this treatment and need ongoing management [2] Group 3: Prevention Strategies - Regular screening and health check-ups are essential for early detection and treatment of viral hepatitis to prevent transmission [4] - Vaccination is the most effective method to prevent hepatitis B, while hepatitis C prevention focuses on avoiding blood exposure and practicing safe behaviors [4] - Maintaining a healthy diet, controlling weight, and reducing liver burden are crucial for liver health [4] - Avoiding excessive alcohol consumption is important as it can lead to liver cell damage and increased liver function indicators [4] - Caution is advised with medication use, as many drugs can be toxic to the liver, and patients should follow medical advice to avoid liver damage [4]